Mania associated with antidepressant treatment: Comprehensive meta-analytic review

Acta Psychiatrica Scandinavica

Volumn 121, Issue 6, 2010, Pages 404-414

  Tondo, L ^a,b,d   Vazquez G ^c   Baldessarini, R J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c UNIVERSITY OF PALERMO   (Argentina)

^d MCLEAN HOSPITAL   (United States)

Author keywords

Antidepressants; Bipolar disorder; Major depression; Mania; Meta analysis

Indexed keywords

ANTIDEPRESSANT AGENT; MONOAMINE OXIDASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

BIPOLAR DISORDER; CLINICAL TRIAL; DISEASE ASSOCIATION; DRUG EXPOSURE; DRUG USE; HUMAN; MAJOR DEPRESSION; MANIA; META ANALYSIS; MOOD DISORDER; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW;

ADULT; AGE FACTORS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANTIMANIC AGENTS; BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; HUMANS; LITHIUM; MIDDLE AGED; MODELS, STATISTICAL; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS;

EID: 77951925706     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2009.01514.x     Document Type: Review

References (113)

1. Ball JR, Kiloh LG. Controlled trial of imipramine in treatment of depressive states. Br Med J 1959 2 : 1052 1055.
2. Keup W, Apolito A, Olinger L, Schwartz M, Yachnes E. Inpatient treatment of depressive states with tofranil (imipramine hydrochloride). Am J Psychiatry 1959 116 : 257 258.
3. Leyberg JT, Denmark JC. The treatment of depressive states with imipramine hydrochloride (Tofranil). J Ment Sci 1959 105 : 1123 1126.
4. Kiloh LG, Child JP, Latner G. A controlled trial of iproniazid in the treatment of endogenous depression. J Ment Sci 1960 106 : 1139 1144.
5. Miller A, Baker EF, Lewis D, Jones A. Imipramine, a clinical evaluation in a variety of settings. Can Psychiatr Assoc J 1960 5 : 150 160.
6. Höhn R, Gross GM, Gross M, Lasagna L. A doubleblind comparison of placebo and imipramine in the treatment of depressed patients in a state hospital. J Psychiatr Res 1961 1 : 76 91.
7. Möller HJ, Grunze H. Have some guidelines for the treatment of acute bipolar depression gone too far in the restriction of antidepressants? Eur Arch Psychiatry Clin Neurosci 2000 250 : 57 68. (Pubitemid 30326316)
8. Angst J, Gamma A. A new bipolar spectrum concept: A brief review. Bipolar Disord 2002 4 : 11 14.
9. Ghaemi SN, Hsu DJ, Soldani F, Goodwin FK. Antidepressants in bipolar disorder: the case for caution. Bipolar Disord 2003 5 : 421 433. (Pubitemid 38072244)
10. Gijsman HJ, Geddes JR, Rendell JM, Nolen WA, Goodwin GM. Antidepressants for bipolar depression: A systematic review of randomized, controlled trials. Am J Psychiatry 2004 161 : 1537 1547. (Pubitemid 39201448)
11. Visser HM, van der Mast RC. Bipolar disorder, antidepressants and induction of hypomania or mania: systemtic review. World J Biol Psychiatry 2005 6 : 231 241.
12. Goodwin GM, Anderson I, Arango C et al. ECNP consensus meeting. Bipolar depression. Nice, March 2007. Eur Neuropsychopharmacol 2008 18 : 535 549.
13. Angst J. Do antidepressant drugs include hypomania/mania? Proceedings of the Annual Congress of the Italian Society of Psychopathology (SOPSI)
14. Wehr TA, Goodwin FK. Can antidepressants cause mania and worsen the course of affective illness? Am J Psychiatry 1987 144 : 1403 1411.
15. Kukopulos A, Reginaldi D, Laddomada P, Floris G, Serra G, Tondo L. Course of the manic-depressive cycle and changes caused by treatment. Pharmakopsychiatr Neuropsychopharmakol 1980 13 : 156 167. (Pubitemid 10048336)
16. Ghaemi SN, Rosenquist KJ, Ko JY, Baldessano CF, Kontos NJ, Baldesssarini RJ. Antidepressant treatment in bipolar vs. unipolar depression. Am J Psychiatry 2004 161 : 163 165. (Pubitemid 38419324)
17. Goodwin FK, Jamison KR, eds. Manic-depressive illness, 2nd edn.
18. Lewis JL, Winokur G. The induction of mania: A natural history with controls. Psychopharmacol Bull 1987 23 : 74 78. (Pubitemid 17111667)
19. McElroy SL, Kotwal R, Kaneria R, Keck PE Jr. Antidepressants and suicidal behavior in bipolar disorder. Bipolar Disord 2006 8 : 596 617. (Pubitemid 44567142)
20. Martin A, Young C, Leckman JF et al. Age effects on antidepressant- induced manic conversion. Arch Pediatr Adolesc Med 2004 158 : 773 780. (Pubitemid 39025076)
21. Baldessarini RJ, Faedda GL, Hennen J. Risk of mania with serotonin reuptake inhibitors vs. tricyclic antidepressants in children, adolescents and young adults. Arch Pediatr Adolesc Med 2005 159 : 298 299.
22. Koukopoulos A, Koukopoulos AE. Agitated depression as a mixed state and the problem of melancholia. Psychiatr Clin North Am 1999 22 : 547 564. (Pubitemid 29463707)
23. Bottlender R, Sato T, Kleindienst N, Strauss A, Möller HJ. Mixed depressive features predict maniform switch during treatment of depression in bipolar I disorder. J Affect Disord 2004 78 : 149 155. (Pubitemid 38045474)
24. Lewis DA, Nasrallah HA. Mania associated with electroconvulsive therapy. J Clin Psychiatry 1986 47 : 366 367.
25. Akiskal HS, Djenderedjian AM, Rosenthal RH, Khani MK. Cyclothymic disorder: validating criteria for inclusion in the bipolar affective group. Am J Psychiatry 1977 134 : 1227 1233.
26. Kukopulos A, Reginaldi D, Laddomada P, Floris G, Serra G, Tondo L. Rapid cyclers, temperament, and antidepressants. Compr Psychiatry 1983 24 : 249 258. (Pubitemid 13059843)
27. Peet M. Induction of mania with selective serotonin reuptake inhibitors and tricyclic antidepressants. Br J Psychiatry 1994 164 : 549 550. (Pubitemid 24141686)
28. Stoll AL, Mayer PV, Kolbrener M et al. Antidepressant-associated mania: A controlled comparison with spontaneous mania. Am J Psychiatry 1994 15 : 1642 1645. (Pubitemid 24337597)
29. Sachs GS, Lafer B, Stoll AL et al. A double-blind trial of bupropion versus desipramine for bipolar depression. J Clin Psychiatry 1994 55 : 391 393. (Pubitemid 24337995)
30. Leverich GS, Altshuler LL, Frye MA et al. Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. Am J Psychiatry 2006 163 : 232 239.
31. Akiskal HS, Hantouche EG, Allilaire JF et al. Validating antidepressant-associated hypomania (bipolar III): A systematic comparison with spontaneous hypomania (bipolar II). J Affect Disord 2003 3 : 65 74.
32. Serretti A, Artioli P, Zanardi R, Rossini D. Clinical features of antidepressant associated manic and hypomanic switches in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 2003 27 : 751 757. (Pubitemid 36966755)
33. DerSimonian R, Laird NM. Meta-analysis in clinical trials. Control Clin Trials 1986 7 : 177 188.
34. Rees L, Davies B. A controlled trial of phenelzine ("Nardil") in the treatment of severe depressive illness. J Ment Sci 1961 107 : 560 566.
35. Bartholomew AA. An evaluation of tranylcypromine ("Parnate") in the treatment of depression. Med J Aust 1962 49 : 655 662.
36. Sharbek A. Trial of amitriptyline in chronic depression. Dis Nerv Syst 1963 24 : 115 119.
37. Browne MW, Kreeger LC, Kazamias NG. A clinical trial of amitriptyline in depressive patients. Br J Psychiatry 1963 109 : 692 694.
38. Gottfries CG. Clinical trial with the monoamido oxidase inhibitor tranylcypromine of a psychiatric clientele. Acta Psychiatr Scand 1963 39 : 463 472.
39. Vahia NS, Bagadia VCN, Doongaji DR. Value of some antidepressants. Hospital Reports by the Medical and Professional Staff of the Jamsetji Jijibhai Hosp Grant Med Coll 1964 9 : 199 203.
40. Klein DF. Chlorpromazine-procyclidine combination, imipramine and placebo in depressive disorders. Can Psychiatr Assoc J 1966 11 (Suppl. 146 149.
41. Prien RF, Klett CJ, Caffey EM. Lithium carbonate and imipramine in prevention of affective episodes. A comparison in recurrent affective illness. Arch Gen Psychiatry 1973 29 : 420 425.
42. Bunney WE Jr. Psychopharmacology of the switch process in affective illness. In : Lipton M, DiMascio A, Killam K, eds. Psychopharmacology: A generation of progress.
43. Van Scheyen JD, van Kammen DP. Clomipramine-induced mania in unipolar depression. Arch Gen Psychiatry 1979 36 : 560 565.
44. Quitkin FM, Kane J, Rifkin A, Ramos-Lorenzi JR, Nayak DV. Prophylactic lithium carbonate with and without imipramine for bipolar 1 patients. A double-blind study. Arch Gen Psychiatry 1981 38 : 902 907. (Pubitemid 11040135)
45. Tondo L, Laddomada P, Serra G, Minnai G, Kukopulos A. Rapid cyclers and antidepressants. Int Pharmacopsychiatry 1981 16 : 119 123. (Pubitemid 11022634)
46. Kane JM, Quitkin FM, Rifkin A, Ramos-Lorenzi JR, Nayak DD, Howard A. Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness: A prospective, placebo-controlled comparison. Arch Gen Psychiatry 1982 39 : 1065 1069. (Pubitemid 12020989)
47. Jann MW, Bitar AH, Rao A. Lithium prophylaxis of tricyclic- antidepressant-induced mania in bipolar patients. Am J Psychiatry 1982 139 : 683 684. (Pubitemid 12158731)
48. Himmelhoch JM, Fuchs CZ, Symons BJ. A double-blind study of tranylcypromine treatment of major anergic depression. J Nerv Ment Dis 1982 170 : 628 634.
49. De Wilde JE, Doogan DP. Fluvoxamine and chlorimipramine in endogenous depression. J Affect Disord 1982 4 : 249 259.
50. Nasrallah HA, Lyskowski J, Schroedere D. TCA-induced mania: Differences between switchers and nonswitchers. Biol Psychiatry 1982 17 : 271 274.
51. Prien RF, Kupfer DJ, Mansky PA et al. Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination. Arch Gen Psychiatry 1984 41 : 1096 1104.
52. Casacchia M, Carolei A, Barba C et al. A placebo-controlled study of the antidepressant activity of moclobemide, a new MAO-A inhibitor. Pharmacopsychiatry 1984 17 : 122 125. (Pubitemid 14089047)
53. Angst J. Switch from depression to mania, or from mania to depression: role of psychotropic drugs. Psychopharmacol Bull 1987 23 : 66 67. (Pubitemid 17111665)
54. Kupfer DJ, Carpenter LL, Frank E. Possible role of antidepressants in precipitating mania and hypomania in recurrent depression. Am J Psychiatry 1988 145 : 804 808.
55. Cohn JB, Collins G, Ashbrook E, Wernicke JF. A comparison of fluoxetine imipramine and placebo in patients with bipolar depressive disorder. Int Clin Psychopharmacol 1989 4 : 313 322.
56. Solomon RL, Rich CL, Darko DF. Antidepressant treatment and the occurrence of mania in bipolar patients admitted for depression. J Affect Disord 1990 18 : 253 257.
57. Johnstone EC, Owens DG, Lambert MT, Crow TJ, Frith CD, Done DJ. Combination tricyclic antidepressant and lithium maintenance medication in unipolar and bipolar depressed patients. J Affect Disord 1990 20 : 225 233.
58. Himmelhoch JM, Thase ME, Mallinger AG, Houck P. Tranylcypromine vs imipramine in anergic bipolar depression. Am J Psychiatry 1991 148 : 910 916.
59. Thase ME, Mallinger AG, McKnight D, Himmelhoch JM. Treatment of imipramine-resistant recurrent depression, IV: A double-blind crossover study of tranylcypromine for anergic bipolar depression. Am J Psychiatry 1992 149 : 195 198.
60. Bocchetta A, Bernardi F, Burrai C, Pedditzi M, Del Zompo M. A double-blind study of L-sulpiride versus amitriptyline in lithium-maintained bipolar depressives. Acta Psychiatr Scand 1993 88 : 434 439. (Pubitemid 24001708)
61. Altshuler LL, Post RM, Leverich GS, Mikalauskas K, Rosoff K. Antidepressant-induced mania and cycle acceleration: A controversy revisited. Am J Psychiatry 1995 152 : 1130 1138.
62. Howland RH. Induction of mania with serotonin reuptake inhibitors. J Clin Psychopharmacol 1996 16 : 425 427. (Pubitemid 26423305)
63. Amsterdam J. Efficacy and safety of venlafaxine in the treatment of bipolar II major depressive episode. J Clin Psychopharmacol 1998 18 : 414 417. (Pubitemid 28462632)
64. Grossman F, Potter WZ, Brown EA, Maislin G. A double-blind study comparing idazoxan and bupropion in bipolar depressed patients. J Affect Disord 1999 56 : 237 243. (Pubitemid 30058228)
65. Young LT, Joffe RT, Robb JC, MacQueen GM, Marriott M, Patells-Siotis I. Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression. Am J Psychiatry 2000 157 : 124 126. (Pubitemid 30027433)
66. Bottlender R, Rudolf D, Strauß A, Möller HJ. Mood-stabilizers reduce the risk of developing antidepressant-induced maniform states in acute treatment of bipolar I depressed patients. J Affect Disord 2001 63 : 79 83. (Pubitemid 32200501)
67. Kupfer DJ, Chengappa KN, Gelenberg AJ et al. Citalopram as adjunctive therapy in bipolar depression. J Clin Psychiatry 2001 62 : 985 990.
68. Silverstone T. Moclobemide vs. imipramine in bipolar depression: A multicentre double-blind clinical trial. Acta Psychiatr Scand 2001 104 : 104 109. (Pubitemid 32656085)
69. Henry C, Sorbara F, Lacoste J, Gindre C, Leboyer M. Antidepressant- induced mania in bipolar patients: Identification of risk factors. J Clin Psychiatry 2001 62 : 249 255. (Pubitemid 32428763)
70. Altshuler L, Kiriakos L, Calcagno J et al. The impact of antidepressant discontinuation versus antidepressant continuation on 1-year risk for relapse of bipolar depression: A retrospective chart review. J Clin Psychiatry 2001 62 : 612 616. (Pubitemid 32848165)
71. Nemeroff CB, Evans DL, Gyulai L et al. Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. Am J Psychiatry 2001 158 : 906 912. (Pubitemid 32547620)
72. Vieta E, Martinez-Arán A, Goikolea JM et al. A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers. J Clin Psychiatry 2002 63 : 508 512. (Pubitemid 34680359)
73. Goldberg JF, Whiteside JE. The association between substance abuse and antidepressant-induced mania in bipolar disorder: A preliminary study. J Clin Psychiatry 2002 63 : 791 795.
74. Altshuler L, Suppes T, Black DO et al. Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up. Am J Psychiatry 2003 160 : 1252 1262. (Pubitemid 41070941)
75. Tohen M, Vieta E, Calabrese J et al. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry 2003 60 : 1079 1088. (Pubitemid 37429647)
76. Amsterdam JD, Shults J. Fluoxetine monotherapy of bipolar type II and bipolar NOS major depression: A double-blind, placebo-substitution, continuation study. Int Clin Psychopharmacol 2005 20 : 257 264. (Pubitemid 41192146)
77. Ghaemi SN, Goodwin FK. Antidepressants for bipolar depression. Am J Psychiatry 2005 162 : 1545 1547.
78. Joffe RT, MacQueen GM, Marriott M, Young LT. One-year outcome with antidepressant-treatment of bipolar depression. Acta Psychiatr Scand 2005 112 : 105 109. (Pubitemid 41003188)
79. Kupka RW, Luckenbaugh DA, Post RM et al. Comparison of rapid-cycling and non-rapid-cycling bipolar disorder based on prospective mood ratings in 539 outpatients. Am J Psychiatry 2005 162 : 1273 1280.
80. Dunner DL, D'Souza DN, Kajdasz DK, Detke MJ, Russell JM. Is treatment-associated hypomania rare with duloxetine: secondary analysis of controlled trials in non-bipolar depression. J Affect Disord 2005 87 : 115 119.
81. Schaffer A, Zuker P, Levitt A. Randomized, double-blind pilot trial comparing lamotrigine versus citalopram for the treatment of bipolar depression. J Affect Disord 2006 96 : 95 99. (Pubitemid 44548053)
82. Wada K, Sasaki T, Jitsuki H et al. Manic/hypomanic switch during acute antidepressant treatment for unipolar depression. J Clin Psychopharmacol 2006 26 : 512 515. (Pubitemid 44401474)
83. Fonseca M, Soares JC, Hatch JP, Santin AP, Kapczinski F. Open trial of adjunctive escitalopram in bipolar depression. J Clin Psychiatry 2006 67 : 81 86. (Pubitemid 43213286)
84. Mundo E, Cattaneo E, Russo M, Altamura AC. Clinical variables related to antidepressant-induced mania in bipolar disorder. J Affect Disord 2006 92 : 227 230. (Pubitemid 44269309)
85. Perlis RH, Ostacher MJ, Patel JK et al. Predictors of recurrence in bipolar disorder: Primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry 2006 163 : 217 224.
86. Koukopoulos A, Sani G, Koukopoulos AE, Albert MJ, Girardi P, Tatarelli R. Endogenous and exogenous cyclicity and temperament in bipolar disorder: review, new data and hypotheses. J Affect Disord 2006 96 : 165 175. (Pubitemid 44827280)
87. Post RM, Altshuler LL, Leverich GS et al. Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline. Br J Psychiatry 2006 189 : 124 131.
88. Truman CJ, Goldberg JF, Ghaemi SN et al. Self-reported history of manic/hypomanic switch associated with antidepressant use: Data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). J Clin Psychiatry 2007 68 : 1472 1479.
89. Sachs GS, Nierenberg AA, Calabrese JR et al. Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med 2007 356 : 1711 1722. (Pubitemid 46658703)
90. Carlson GA, Finch SJ, Fochtmann LJ et al. Antidepressant-associated switches from depression to mania in severe bipolar disorder. Bipolar Disord 2007 9 : 851 859.
91. Amsterdam JD, Shults J. Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode. J Clin Psychopharmacol 2008 28 : 171 181.
92. McElroy S, Olausson B, Chang W, et al. A double-blind, placebo-controlled study with acute and continuation phase of quetiapine in adults with bipolar depression (EMBOLDEN II). Proc 3rd Biennial Conference of the International Society for Bipolar Disorders.
93. Goldberg JF, Truman CJ. Antidepressant-induced mania: An overview of current controversies. Bipolar Disord 2003 5 : 407 420.
94. Benvenuti A, Rucci P, Miniati M et al. Treatment-emergent mania/hypomania in unipolar patients. Bipolar Disord 2008 10 : 726 732.
95. Akiskal HS, Akiskal KK, Lancrenon S et al. Validating the bipolar spectrum in the French National EPIDEP Study: overview of the phenomenology and relative prevalence of its clinical prototypes. J Affect Disord 2006 96 : 197 205. (Pubitemid 44834419)
96. Angst J, Sellaro R, Stassen HH, Gamma A. Diagnostic conversion from depression to bipolar disorders: results of a long-term prospective study of hospital admissions. J Affect Disord 2005 84 : 149 157. (Pubitemid 40222496)
97. Akiskal HS, Maser JD, Zeller P et al. Switching from "unipolar" to bipolar II: 11-year prospective study of clinical and temperamental predictors in 559 patients. Arch Gen Psychiatry 1995 52 : 114 123.
98. Klerman GL. The spectrum of mania. Compr Psychiatry 1981 22 : 11 20.
99. Akiskal HS, Pinto O. The evolving bipolar spectrum: Prototypes I, II, III, IV. Psychiatr Clin North Am 1999 22 : 517 534. (Pubitemid 29463705)
100. Post RM, Leverich GS, Nolen WA et al. Re-evaluation of the role of antidepressants in the treatment of bipolar depression: Data from the Stanley Foundation Bipolar Network. Bipolar Disord 2003 5 : 396 406.
101. Licht RW, Gijsman H, Nolen W, Angst J. Are antidepressants safe in the treatment of bipolar depression? A critical evaluation of their potential risk to induce switch into mania or cycle-acceleration. Acta Psychiatr Scand 2008 118 : 337 346.
102. Salvi V, Fagiolini A, Swartz HA, Maina G, Frank E. Use of antidepressants in bipolar disorder. J Clin Psychiatry 2008 69 : 1307 1318.
103. Reginaldi D, Tondo L, Floris G, Pignatelli A, Kukopolos A. Poor prophylactic lithium response due to antidepressants. Int Pharmacopsychiatry 1981 16 : 124 128.
104. Baldessarini RJ, Tarazi FI. Pharmacotherapy of psychosis and mania. Chapt 18 In : Brunton LL, Lazo JS, Parker KL, eds. Goodman and Gilman's the pharmacological basis of therapeutics, 11th edn.
105. Henry C, Demotes-Mainard J. Avoiding drug-induced switching in patients with bipolar depression. Drug Saf 2003 26 : 337 351. (Pubitemid 36433832)
106. Baldessarini RJ, Leahy L, Arcona S, Gause D, Zhang W, Hennen J. Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders. Psychiatr Serv 2007 58 : 85 91. (Pubitemid 46261779)
107. Baldessarini RJ, Henk HJ, Sklar AR, Chang J, Leahy LF. Use of psychotropic medicines in bipolar disorder patients in the United States. Psychiatr Serv 2008 59 : 1175 1183.
108. 2-like receptor agonist quinpirole. Eur J Pharmacol 2006 535 : 208 211.
109. DeLuca V, Mundo E, Trakalo J, Wong GW, Kennedy JL. Investigation of polymorphism in the MDR1 gene and antidepressant-induced mania. Pharmacogenomics J 2003 3 : 297 299. (Pubitemid 37428194)
110. Barr M, Rose D. The great ambivalence: Factors likely to affect service user and public acceptability of the pharmacogenomics of antidepressant medication. Sociol Health Illn 2008 30 : 944 958.
111. Eppel AB. Antidepressants in the treatment of bipolar disorder: Decoding contradictory evidence and opinion. Harv Rev Psychiatry 2008 16 : 205 209. (Pubitemid 351883196)
112. Lin E, Chen PS. Pharmacogenomics with antidepressants in the STAR*D study. Pharmacogenomics 2008 9 : 935 946.
113. Yadid G, Friedman A. Dynamics of the dopaminergic system as a key component to the understanding of depression. Progr Brain Res 2008 172 : 265 286.